Clinical trial
Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear…
NCT00185081 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00185081 |
|---|---|
| Title | Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging |
| Official title | Radioimmunodetection of CEA-Producing Tumors Using a Bispecific Antibody Pre-targeting Method and an In-Labeled Peptide |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Gilead Sciences Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colonic Neoplasms |
| Intervention type | Drug |
| Interventions | Indium labeled IMP-205xm734 |
| Enrollment | 42 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 7, 2016 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: